1. Ren, Na, Liang, Bin, Li, Yunhui. . Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets. In Bioscience reports, 40, . doi:10.1042/BSR20200980. https://pubmed.ncbi.nlm.nih.gov/33015704/
2. Hu, Pengbo, Zhang, Xiuyuan, Li, Yiming, Xu, Liang, Qiu, Hong. 2022. Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration. In Frontiers in genetics, 13, 882794. doi:10.3389/fgene.2022.882794. https://pubmed.ncbi.nlm.nih.gov/35873458/
3. Lin, Jiaxing, Xu, Xiao, Li, Tianren, Zhu, Yuyan, Sun, Dan. 2021. OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts. In Frontiers in oncology, 11, 650678. doi:10.3389/fonc.2021.650678. https://pubmed.ncbi.nlm.nih.gov/34868901/
4. Liu, Jiaxin, Liu, Zhao, Zhang, Xiaozhi, Gong, Tuotuo, Yao, Demao. 2019. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools. In BMC cancer, 19, 227. doi:10.1186/s12885-019-5406-x. https://pubmed.ncbi.nlm.nih.gov/30866865/